“The total amount spent on MS medications increased 25.4% from 2009-2010.  The amount had increased 34.4% from 2008-2009 and 18.3% from 2007-2008.  The result is an amount spent in 2010 on MS medications which is double what what spent in 2007.  Double in three years.  If forecasts are correct, the amount spent on MS drugs will more than double again in three years.Much of this increase is due to an increase in the price of each medication.  The price for Copaxone was increased 19% according to the 2010 Drug Trend Report, while utilization for MS drugs is actually decreasing slightly.  It is not expected that the introduction of new medications will cause prices to go lower and we’ve seen this already with the introduction of Gilenya in September 2010.  The market response to Gilenya’s $48,000 price tag was an increase in price of other MS medications, not a decrease (see The Rising Price of MS Disease-Modifying Medications)

I just wonder if this racing train will ever slow down.
This abstract is taken from Lisa Emrich’sarticle “MS Medication Costs Increase 25.4% in 2010″.

The answer to this last question of course is that the race will never slow down as long as the healthcare system all over the world is based on profits. No reasearch is willing to really solve the problem but all are more than willing to just moderate it and continue to sell their products. Especially when we are in the middle of an economic crisis and the profits need to find new ways of speculation. Health has nothing to do with profits as well as other areas of human activity.
That is exactly the reason why the term “patient” is always follwed by the term “consumer” and of course the latter is always the challenge…